本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

0.8586
-0.0214-2.43%
盘后0.8515-0.0071-0.83%16:50 EDT
成交量:7.75万
成交额:6.69万
市值:433.67万
市盈率:-0.06
高:0.8850
开:0.8850
低:0.8512
收:0.8800
数据加载中...
2025/04/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/24

SEC问询函

Form CORRESP - Correspondence
2025/01/17

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/11/20

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC问询函

Form CORRESP - Correspondence
2024/08/12

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/08/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/12

SEC问询函

Form CORRESP - Correspondence
2024/06/06

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/21

SEC问询函

Form CORRESP - Correspondence
2024/03/18

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]